United States

CombiMatrix Corp (CBMX.OQ)

CBMX.OQ on NASDAQ Stock Exchange Capital Market

20 Jan 2017
Change (% chg)

$-0.15 (-4.69%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for CBMX.OQ


CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be... (more)


Beta: 0.88
Market Cap(Mil.): $7.63
Shares Outstanding(Mil.): 2.50
Dividend: --
Yield (%): --


  CBMX.OQ Industry Sector
P/E (TTM): -- 36.23 30.38
EPS (TTM): -6.92 -- --
ROI: -69.51 8.62 14.86
ROE: -97.65 12.12 16.28

BRIEF-Combimatrix's pre-implantation genetic screening granted conditional approval

* combimatrix's pre-implantation genetic screening by next generation sequencing granted conditional approval from New York state department of health

Nov 29 2016

BRIEF-Combimatrix Corp reports Q3 loss per share $0.38

* Combimatrix Corporation reports third quarter 2016 financial and operating results

Nov 02 2016

BRIEF-Combimatrix notes decision to reimburse for recurrent pregnancy loss testing

* Combimatrix notes decision by health care service corporation to reimburse for recurrent pregnancy loss testing Source text for Eikon: Further company coverage:

Aug 16 2016

BRIEF-Combimatrix reports agreement with Universal Labs

* Combimatrix announces distribution agreement with universal diagnostic laboratories for miscarriage analysis testing

Aug 10 2016

BRIEF-Combimatrix Reports Q2 loss per share $0.89

* Combimatrix corporation reports second quarter 2016 financial and operating results

Aug 03 2016


Earnings vs. Estimates